help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Y.
Right arrow Articles by Li, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Y.
Right arrow Articles by Li, B.
Endocrinology Vol. 144, No. 5 2068-2074
Copyright © 2003 by The Endocrine Society

Activation of p38 Mitogen-Activated Protein Kinase Is Required for Osteoblast Differentiation

Yuanyu Hu, Emily Chan, Sherry X. Wang and Baojie Li

Institute of Molecular and Cell Biology, National University of Singapore, Singapore 117609

Address all correspondence and requests for reprints to: Dr. Baojie Li, Institute of Molecular and Cell Biology, National University of Singapore, 30 Medical Drive, Singapore 117609. E-mail: libj{at}imcb.nus.edu.sg.

p38 MAPK is a conserved subfamily of MAPKs involved in inflammatory response, stress response, cell growth and survival, as well as differentiation of a variety of cell types. In this report we demonstrated that p38 MAPK played an important role in osteoblast differentiation using primary calvarial osteoblast, bone marrow osteoprecursor culture, and a murine cell line, MC3T3-E1. We found that p38 MAPK was activated as calvarial osteoblast differentiates along with extracellular signal-regulated kinases (ERKs). When p38 MAPK is inhibited with a specific inhibitor, the expression of differentiation markers, such as alkaline phosphatase and mineral deposition, were significantly reduced. MC3T3-E1 cells expressing dominant negative p38 MAPK also displayed signs of delay in ALP and mineral deposition. Differentiation of the bone marrow osteoprecursors was also impeded by the p38 MAPK inhibitor, justified by the same markers. Yet the inhibitory effects observed in calvarial osteoblasts and bone marrow osteoprogenitor cells could be partially prevailed by bone morphogenetic protein-2. Inhibition of ERKs with a specific drug did not significantly affect osteoblast differentiation even though ERK1/2 were also activated during osteoblast differentiation. These results taken together indicate that p38 MAPK, but not ERKs, is necessary for osteoblast differentiation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. Grenier, F. S. Maupas, J.-F. Beaulieu, E. Seidman, E. Delvin, A. Sane, E. Tremblay, C. Garofalo, and E. Levy
Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1178 - G1189.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Caverzasio and D. Manen
Essential Role of Wnt3a-Mediated Activation of Mitogen-Activated Protein Kinase p38 for the Stimulation of Alkaline Phosphatase Activity and Matrix Mineralization in C3H10T1/2 Mesenchymal Cells
Endocrinology, November 1, 2007; 148(11): 5323 - 5330.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Wang, C. H. Goh, and B. Li
p38 Mitogen-Activated Protein Kinase Regulates Osteoblast Differentiation through Osterix
Endocrinology, April 1, 2007; 148(4): 1629 - 1637.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. M. Pino, J. M. Rodriguez, S. Rios, P. Astudillo, L. Leiva, G. Seitz, M. Fernandez, and J P. Rodriguez
Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin
J. Endocrinol., December 1, 2006; 191(3): 715 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Lu, L. Gilbert, X. He, J. Rubin, and M. S. Nanes
Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NF{kappa}B Pathways
J. Biol. Chem., March 10, 2006; 281(10): 6297 - 6306.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P.-L. Kuo, Y.-L. Hsu, C.-H. Chang, and J.-K. Chang
Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1290 - 1299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society